Jerome Groopman
Jerome Groopman has been a staff writer in medicine and biology for The New Yorker since 1998. He is Professor of Medicine at Harvard Medical School, Chief of Experimental Medicine at Beth Israel Deaconess Medical Center, and author of four books. He has published around 150 scientific articles, and has written several Op-Ed pieces on medicine for the New York Times, the Washington Post, and The New Republic.
Dr. Groopman received his BA and MD from Columbia College and was at the Massachusetts General Hospital for his internship and residency in internal medicine. This was followed by fellowships in hematology and oncology at the University of California and the Sidney Farber Cancer Center at the Harvard Medical School in Boston.
Much of Dr. Groopman’s research has focused on the basic mechanisms of cancer and AIDS. He did seminal work on identifying growth factors which may restore the depressed immune systems of AIDS patients. He performed the first clinical trials in a technique that augments blood cell production in immunodeficient HIV-infected patients and has been a major participant in the development of many AIDS-related therapies including AZT. Recently, Dr. Groopman has extended the research infrastructure in genetics and cell biology to studies in breast cancer and neurobiology.
The first book written by Dr. Groopman was The Measure of Our Days, published in 1997. Since then he has written 3 more books; Second Opinions in 2000, Anatomy of Hope in 2004, and his latest, How Doctors Think, which comes out March 2007.